首页|布地奈德联合孟鲁司特对支气管哮喘急性发作患儿的影响

布地奈德联合孟鲁司特对支气管哮喘急性发作患儿的影响

扫码查看
目的:观察布地奈德联合孟鲁司特对支气管哮喘急性发作患儿的影响.方法:回顾性选取2021年1月—2022年12 月泉州市妇幼保健院·儿童医院收治的 98 例支气管哮喘急性发作患儿的病历资料.根据不同治疗方法将其分为观察组和对照组,各 49 例.对照组采用布地奈德治疗,观察组在对照组基础上给予孟鲁司特钠治疗.比较两组治疗 2 周后临床疗效,治疗前后免疫功能、炎症因子及药物安全性.结果:观察组总有效率明显高于对照组,差异有统计学意义(P<0.05).治疗后,两组免疫球蛋白A(IgA)、免疫球蛋白M(IgM)水平升高,补体C3 水平下降,观察组IgA、IgM水平均高于对照组,补体C3 水平低于对照组,差异有统计学意义(P<0.05).治疗后,两组白细胞(WBC)计数、C反应蛋白(CRP)均降低,观察组WBC计数、CRP均低于对照组,差异有统计学意义(P<0.05).观察组皮疹与声音沙哑发生例数略多于对照组,但两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:布地奈德联合孟鲁司特治疗较单一的布地奈德治疗方法效果更佳,免疫功能恢复更好,并有效调节血清细胞因子水平.
Effects of Budesonide Combined with Montelukast on Children with Acute Attack of Bronchial Asthma
Objective:To observe the effects of Budesonide combined with Montelukast on children with acute attack of bronchial asthma.Method:The medical records of 98 children with acute attack of bronchial asthma admitted to Quanzhou Maternal and Child Health Hospital·Children's Hospital from January 2021 to December 2022 were retrospectively selected.According to different treatment methods,they were divided into observation group and control group,49 cases in each group.The control group was treated with Budesonide and the observation group was treated with Montelukast Sodium on the basis of the control group.The clinical efficacy after 2 weeks of treatment,immune function,inflammatory factors before and after treatment and drug safety of the two groups were compared.Result:The total effective rate of the observation group was significantly higher than that of the control group,and the difference was statistically significant(P<0.05).After treatment,the levels of immunoglobulin A(IgA)and immunoglobulin M(IgM)increased and the level of complement C3 decreased in both groups,the levels of IgA and IgM in the observation group were higher than those in the control group,and the level of complement C3 was lower than that in the control group,the differences were statistically significant(P<0.05).After treatment,white blood cell(WBC)count and C-reactive protein(CRP)were decreased in both groups,and WBC count and CRP in observation group were lower than those in control group,the differences were statistically significant(P<0.05).The incidence of rashes and hoarseness in the observation group was slightly higher than that in the control group,but there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Compared to treatment with Budesonide alone,the combined treatment of Budesonide and Montelukast is more effective for children with acute attack of bronchial asthma.The latter is more conducive to immune function recovery and can effective regulate serum cytokines levels.

BudesonideMontelukastBronchial asthmaImmune functionCytokinesDrug safety

吴文彬、洪婉倩

展开 >

泉州市妇幼保健院·儿童医院 福建 泉州 362000

布地奈德 孟鲁司特 支气管哮喘 免疫功能 细胞因子 药物安全

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(20)